The General Hospital works across all the medical specialisms and most of the surgical specialisms in adults. We are a level 3 hospital, which means that we specialise in severe, acute and critical patients and we handle clinical cases with the highest degree of severity and complexity.
We handle more than 1.2 million patients a year, many of whom also have the option to take part in clinical trials run by our research teams. This proximity between the labs and the hospitals gives us added value. The fluidity between research and care thus allows us to translate the knowledge from research and care into improving patient health.
Our fields of excellence are adult and paediatric organ and tissue transplants. We are pioneers in the creation of the role of transplant coordinator, who facilitates the transition and integration of paediatric patients to adults.
Another strong point of our care activity is our cancer care, which is based on clinical and basic research conducted on the hospital campus. We are the centre that handles most cancer cases in Catalonia, both in adults and children. We have highly specialised multidisciplinary teams and incorporate all preventive, diagnostic and therapeutic aspects (including personalised therapy and the use of genome platforms).
The General Hospital also boasts the first haematology-specific day hospital in Spain. Opened in 2016, it is a 400-metres-squared space with advanced equipment that seeks to improve the quality of life of patients and save hospital admissions.
Located on the second floor of the General Hospital, the Stroke Unit incorporates pioneering equipment available to medical staff, such as a Doppler ultrasound unit, a cardiac echocardiography unit and a vascular neurosurgery room. In addition, it has non-invasive technology that assesses patient cerebral circulation and is controlled centrally.
Finally, it is worth mentioning the Cardiology Department, which runs the CSUR Unit for hereditary heart disease, so-called "family or congenital heart disease". Its advance heart surgery techniques, alongside translational research and multidisciplinary programmes, have given more positive results in this high prevalence disease: 250 cases for every 100,000 inhabitants.
De Souza Galvão
There are more than 3,000 nurses and nursing assistants at Hospital Vall d’Hebron. The work they do in the centre is vital and they are leaders both in nursing care and research. Getting to this point was a long process, as Mariona Creus, former nursing director, and Maria Àngels Barba, the current director, recall.
The winning proposal for the transformation of the Vall d’Hebron Campus is the project directed by Jordi Badia, Antoni Ubach and Miquel Espinet. The project presented by the architects includes a new research building for the Vall d'Hebron Research Institute, with an expandable area of 5,000 m2 and a budget of €15 million funded by ERDF (European Regional Development Fund).
The constant search for excellence is part of Hospital Vall d’Hebron’s nature. The biggest hospital in Catalonia and the leader in many fields, headed since February 2015 by Dr. Vicenç Martínez Ibáñez, who has a close personal and professional relationship with the Hospital. Dr. Martínez Ibáñez says that if Vall d’Hebron did not exist, it would need to be invented. The current director trained at the hospital, where he was one of the protagonists of an historic moment: the first paediatric liver transplant in Spain. Now, he is committed to continuing this legacy and, always putting the patient first, achieving excellence across all staff.
The Vall d’Hebron Digestive Endoscopy Department, now run by Dr. Joan Dot, who took over the role from Dr. Josep Ramon Armengol, who runs WIDER in Barcelona (World Institute for Digestive Endoscopy Research), cares for 70 patients a day with complex procedures and is one of the centres leading the colon cancer screening programme.